Neonatal cholestasis

Sridevi Venigalla1, Glenn R Gourley

  • 1Department of Pediatrics, Oregon Health & Science University, Portland, OR 97239-2998, USA.

Seminars in Perinatology
|February 3, 2005
PubMed

Insights

Persistent infant jaundice beyond three weeks requires evaluation for neonatal cholestasis, a condition of impaired bile excretion. Early diagnosis and intervention, especially for biliary atresia, are crucial for infant health outcomes.

Area of Science:

  • Neonatology
  • Pediatric Gastroenterology
  • Hepatology

Background:

  • Neonatal cholestasis is defined as impaired bile excretion leading to bile substance accumulation.
  • Persistent jaundice beyond 2-3 weeks necessitates evaluation for this condition.
  • Differentiating conjugated from unconjugated hyperbilirubinemia is critical for diagnosis.

Purpose of the Study:

  • To outline the evaluation and diagnosis of neonatal cholestasis.
  • To highlight key clinical features and differential diagnoses.
  • To emphasize the importance of timely intervention for specific conditions like biliary atresia.

Main Methods:

  • Evaluation of infants with prolonged jaundice.
  • Fractionated serum bilirubin level assessment.
  • Systematic differential diagnosis approach.

Main Results:

  • Conjugated hyperbilirubinemia, pale stools, and dark urine are key indicators.
  • Biliary atresia is a frequent cause requiring early surgical intervention (before 60 days).
  • Premature infants present unique challenges requiring modified evaluation.

Conclusions:

  • Prompt evaluation of prolonged infant jaundice is essential.
  • A systematic diagnostic approach aids in identifying causes like biliary atresia.
  • Management focuses on supportive care, complication management, and nutritional support.

Related Concept Videos

Cholecystitis01:20

Cholecystitis

Cholecystitis is inflammation of the gallbladder, most commonly caused by obstruction of the cystic duct. This blockage prevents bile from draining, leading to gallbladder distension, inflammation, and potentially serious complications. This condition may present acutely or chronically and can happen with or without gallstones.EtiologyAbout 95% of cholecystitis cases are calculous, caused by gallstones blocking the cystic duct, leading to bile accumulation and inflammation of the gallbladder...
Jaundice01:25

Jaundice

Jaundice, or icterus, is the yellow discoloration of the skin, sclerae, and mucous membranes. It happens when plasma bilirubin levels rise above 2.5-3 mg/dL, leading to bilirubin deposition in tissue.Bilirubin is a byproduct of hemoglobin degradation. In macrophages, hemoglobin breaks down into globin and heme. Globin is converted into amino acids, while heme is turned into biliverdin by heme oxygenase, which is then reduced to unconjugated bilirubin by biliverdin reductase.Unconjugated...
Hepatic Encephalopathy01:29

Hepatic Encephalopathy

DefinitionHepatic encephalopathy is a reversible neurologic syndrome that results from advanced liver dysfunction or portosystemic shunting. It leads to disturbances in cognition, behavior, and motor function due to the brain’s exposure to gut-derived toxins that the liver fails to detoxify.EtiologyThis condition develops either in the setting of acute fulminant hepatitis or progressively during chronic liver disease, such as cirrhosis and portal hypertension. Portosystemic shunting—including...
Diseases of the Liver and Gallbladder01:26

Diseases of the Liver and Gallbladder

Liver and gallbladder diseases are a significant health concern, with prominent conditions including cirrhosis, hepatitis, non-alcoholic fatty liver disease (NAFLD), and gallstones. Jaundice is a common manifestation of liver and biliary disease.
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not related to...